Matrix Capital Management Company, LP - Q2 2021 holdings

$9.15 Billion is the total value of Matrix Capital Management Company, LP's 23 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 30.0% .

 Value Shares↓ Weighting
NFLX  NETFLIX INC$1,056,420,000
+1.3%
2,000,0000.0%11.54%
-4.2%
CRWD  CROWDSTRIKE HLDGS INCcl a$753,930,000
+37.7%
3,000,0000.0%8.24%
+30.3%
DIS  DISNEY WALT CO$738,234,000
-4.7%
4,200,0000.0%8.06%
-9.9%
TDG  TRANSDIGM GROUP INC$708,718,000
+10.1%
1,094,9000.0%7.74%
+4.2%
TWLO BuyTWILIO INCcl a$688,020,000
+303.8%
1,745,536
+249.1%
7.52%
+282.1%
CRM  SALESFORCE COM INC$640,551,000
+15.3%
2,622,3090.0%7.00%
+9.1%
ADPT SellADAPTIVE BIOTECHNOLOGIES COR$482,152,000
-2.7%
11,800,090
-4.1%
5.27%
-8.0%
QCOM  QUALCOMM INC$477,009,000
+7.8%
3,337,3600.0%5.21%
+2.0%
GPN  GLOBAL PMTS INC$461,834,000
-7.0%
2,462,5880.0%5.04%
-12.0%
AMAT  APPLIED MATLS INC$429,051,000
+6.6%
3,013,0000.0%4.69%
+0.8%
ALTR BuyALTAIR ENGR INC$361,749,000
+12.2%
5,245,025
+1.7%
3.95%
+6.1%
MU BuyMICRON TECHNOLOGY INC$339,920,000
+9.6%
4,000,000
+13.8%
3.71%
+3.7%
NEWR  NEW RELIC INC$334,850,000
+8.9%
5,000,0000.0%3.66%
+3.0%
BIGC BuyBIGCOMMERCE HLDGS INC$305,124,000
+35.4%
4,700,000
+20.5%
3.33%
+28.0%
XLNX  XILINX INC$303,744,000
+16.7%
2,100,0000.0%3.32%
+10.5%
WDAY  WORKDAY INCcl a$252,120,000
-3.9%
1,056,0430.0%2.75%
-9.1%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$218,159,000
+31.6%
4,100,739
+7.3%
2.38%
+24.4%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$166,030,000
-19.8%
38,974,1850.0%1.81%
-24.1%
CDNA BuyCAREDX INC$159,227,000
+62.5%
1,739,807
+20.9%
1.74%
+53.8%
DT  DYNATRACE INC$146,050,000
+21.1%
2,500,0000.0%1.60%
+14.5%
VRNS  VARONIS SYS INC$71,880,000
+12.2%
1,247,4870.0%0.78%
+6.1%
KNBE NewKNOWBE4 INCcl a$29,707,000950,000
+100.0%
0.32%
RNA  AVIDITY BIOSCIENCES INC$29,652,000
+13.3%
1,200,0000.0%0.32%
+7.3%
COUP ExitCOUPA SOFTWARE INC$0-17,500
-100.0%
-0.05%
WISH ExitCONTEXTLOGIC INC$0-1,000,000
-100.0%
-0.18%
SILK ExitSILK RD MED INC$0-538,700
-100.0%
-0.32%
CSTL ExitCASTLE BIOSCIENCES INC$0-1,000,000
-100.0%
-0.79%
LRCX ExitLAM RESEARCH CORP$0-150,000
-100.0%
-1.03%
AMZN ExitAMAZON COM INC$0-51,500
-100.0%
-1.84%
VCYT ExitVERACYTE INC$0-2,977,027
-100.0%
-1.85%
INTC ExitINTEL CORP$0-3,022,000
-100.0%
-2.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC42Q3 202313.3%
WORKDAY INC42Q3 202319.7%
NETFLIX INC37Q2 202226.1%
NEW RELIC INC29Q1 20227.8%
DAVITA INC26Q3 20196.1%
ADAPTIMMUNE THERAPEUTICS PLC26Q3 20236.8%
SALESFORCE INC23Q3 202218.4%
CONSTELLATION BRANDS INC23Q2 20195.7%
AMAZON COM INC21Q3 202311.2%
TABLEAU SOFTWARE INC20Q2 201915.2%

View Matrix Capital Management Company, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Matrix Capital Management Company, LP Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adaptimmune Therapeutics PLCJuly 10, 2023233,845,11017.3%
Zentalis Pharmaceuticals, Inc.June 20, 202313,959,97319.8%
ForgeRock, Inc.Sold outFebruary 13, 202300.0%
NEW RELIC, INC.Sold outFebruary 13, 202300.0%
Perimeter Solutions, SAFebruary 13, 20238,587,5005.4%
Aura Biosciences, Inc.December 07, 20225,362,87014.5%
Adaptive Biotechnologies CorpFebruary 14, 202211,572,5908.2%
BigCommerce Holdings, Inc.Sold outFebruary 14, 202200.0%
CarGurus, Inc.Sold outFebruary 16, 202100.0%
Trillium Therapeutics Inc.Sold outFebruary 14, 202000.0%

View Matrix Capital Management Company, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
42023-11-09
SC 13D/A2023-11-09
13F-HR2023-08-14
SC 13G/A2023-07-10
42023-06-20
SC 13D/A2023-06-20
13F-HR2023-05-15

View Matrix Capital Management Company, LP's complete filings history.

Compare quarters

Export Matrix Capital Management Company, LP's holdings